BioOra

Discover BioOra's innovative approach in automating CAR T Therapy, enhancing access and efficiency in cell therapy manufacturing.

Health and bioManufacturing and industrial

BioOra raised $16.84M in a Series A round announced October 1, 2026, according to startupresearcher.com. Investors in that round: Cincinnati Children’s, Bridgewest Ventures.

Team

• JR
  John Robson Managing Director
• LC
  Laurence Cooper Global Chief Medical Officer
• SD
  Steve Davis Board member

Raise history

1. October 1, 2026
   Series A · $16.84M
   CCincinnati Children’s (lead), BBridgewest Ventures
   Source: startupresearcher.com
2. July 6, 2021
   X account created
3. April 19, 2021
   Website created

Investors

• AAngel Investors Marlborough
• BBridgewest Ventures
• CCallaghan Innovation
• CCincinnati Children’s

Related bio health companies

• SSunfox$7M · Oct 7, 2026
• AAlteogen$150M · Oct 6, 2026
• SSynvareOct 6, 2026
• SSuperMush$3M · Oct 6, 2026
• RRougeTx$58M · Oct 6, 2026
• AArcheon Medical$9M · Oct 6, 2026
• KKymaThera$80M · Oct 6, 2026
• AArboretum$30M · Oct 6, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/bioora.